TECNOSS HISTORY

Giuseppe Oliva, MD, founder of Tecnoss®, created in 1995 a patented biological tissues conditioning process, capable of obtaining biocompatible collagenated grafts implantable in different species.

Director of Tecnoss® since 2001 he graduated in Medicine in 1974, practicing dentistry since 1977, with main focus in implantology and regenerative surgery since 1982.

In 2004 he was a speaker at Orthopedics Ortho Mare Nostrum (17-19 June) and SO.TI.MI. (1-3 July) Congress.
“Producing a heterologous bone substitute as close as possible to autologous bone” has always been his primary goal.

MARCH 1998

Tecnoss foundation – a new vision of the future of biomaterials taking shape

MARCH 2000

First CE 0373 Medical Devices mark approved for Gen-Os® biomaterials line (bone substitute and membrane) – new Dual-Phase bone matrix ready combining mineral and collagen phases

JUNE 2000

CE 0373 Medical Device mark approved for Special membrane

APRIL 2001

Introduction of OsteoBiol® brand

JULY 2002

CE 0373 Medical Devices mark approved for Putty and MU bone paste – 1st revolutionary innovation in biomaterials market

MARCH 2003

CE 0373 Medical Devices mark approved for Duo-Teck and Button collagen felt – innovation combined with simplicity

SEPTEMBER 2005

CE 0373 Medical Devices mark approved for Evolution membrane – the state of the art in biological barriers for grafting materials

JULY 2008

CE 0373 Medical Devices mark approved for mp3® ready to use biomaterials – prehydrated and collagenated

APRIL 2009

Introduction of Tecnoss® brand in hospital medical market

NOVEMBER 2009

CE 0373 Medical Devices mark approved for Graftygen® – Derma

DICEMBER 2011

CE 0373 Medical Device mark approved for Tecnoss® Protexa® – a new standard for dermal matrices

MAY 2016

CE 0373 Medical Device mark approved for TSV-Gel: 2nd revolution in biomaterials market – improved handling via thermosensitive viscosity gel

MAY 2018

CE 0373 Medical Device mark approved for GTO®: the new standard of excellence in biomaterials